BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230 USD | -2.24% |
|
+4.70% | -11.10% |
| 05-16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| 05-16 | Sector Update: Health Care Stocks Ease Thursday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
2024-06-20
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
235.3
USD
Average target price
285.9
USD
Spread / Average Target
+21.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.10% | 34.26B | |
| +0.10% | 91.42B | |
| +3.16% | 41.08B | |
| +53.99% | 25.27B | |
| -9.41% | 12.81B | |
| -12.25% | 11.6B | |
| -44.00% | 11.42B | |
| +5.77% | 9.16B | |
| -6.90% | 8.22B | |
| -7.11% | 7.06B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Sector Update: Health Care